Speaker Profile
Biography
With extensive experience in nanoparticle engineering, drug formulation, process development, and biotechnology commercialization, Eddie leads Coastar’s mission to overcome critical barriers in genetic medicine.
Under his leadership, Coastar is advancing its proprietary Erythrocyte-Derived Membrane (EDM) platform, designed to enhance immune evasion, improve targeted delivery, and enable safer, more effective in vivo therapies. The platform has broad applications across gene therapy, cell therapy, and oncology.
Eddie combines scientific expertise with entrepreneurial vision, driving strategic partnerships, technology development, and fundraising initiatives to accelerate the translation of innovative research into clinical solutions. He is committed to making advanced genetic medicines more accessible, scalable, and transformative for patients worldwide.
Talk
Unlocking Genetic Medicine with Nature’s Trojan Horse
Coastar Therapeutics is reimagining genetic medicine with its erythrocyte-derived membrane (EDM) delivery platform. By coating viral vectors and nonviral payloads with red blood cell membranes, EDM aims to reduce immune clearance, improve targeting, and enable repeat dosing, advancing more accessible in vivo CAR-T therapies for cancer and autoimmune diseases.
Emerging Therapeutics Showcase:
Coastar Therapeutics Inc.
Coastar Therapeutics is a San Diego-based biotechnology company pioneering a proprietary erythrocyte-derived membrane (EDM) platform to enable safer, more efficient, and targeted delivery of genetic medicines. By overcoming key challenges in immune clearance, targeting, and repeat dosing, Coastar aims to revolutionize in vivo CAR-T therapies and make advanced treatments for cancer and autoimmune diseases more accessible and affordable.
Session Abstract – PMWC 2027 Silicon Valley
The PMWC 2027 Emerging Therapeutics Showcase will provide a 15-30 minute time slot for selected companies and researchers in the CRISPR, Cell and Gene Therapy fields. Major advancements in safer cell- and gene-level editing technologies are bringing us closer toward cures for life-threatening disorders, from cancer to HIV to Huntington’s disease. Cell therapy, in which cellular material such as T cells capable of fighting cancer cells, is injected into a patient, has been demonstrated safe and effective. The popular new CRISPR tool that has been used to edit the genetic code of nearly any organism will have an enormous impact on human health. More than a dozen clinical trials employing CRISPR on human cells are already underway.
- Emerging Therapeutics/Cell Therapy
- Emerging Therapeutics/CVD
- Emerging Therapeutics/Gene Therapy
- Emerging Therapeutics/Immunotherapy
- Emerging Therapeutics/Radiation Therapy
Davos of Precision Medicine
PMWC 2027 Program
January 27–29, 2027 · Santa Clara Convention Center
Swipe speakers · Tap a card for sessions →
In a few words.
PMWC is indeed The Davos of Biotech
Day 1 / Wed · Jan 27
Day 2 / Thu · Jan 28
Day 3 / Fri · Jan 29
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
